ARTICLE | Clinical News
Accofil filgrastim regulatory update
August 4, 2014 7:00 AM UTC
EMA’s CHMP issued a positive opinion recommending approval of an MAA from Intas’ Accord Healthcare Ltd. subsidiary for Accofil filgrastim. The product is a biosimilar of Neupogen filgrastim, a recomb...